Six minute walk test Z score: correlations with cystic fibrosis severity markers

Fabíola Stollar1, Joaquim C Rodrigues, Maristela T Cunha

  • 1Pulmonology Division, Instituto da Criança, Hospital das Clínicas, University of São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 647, zip code 05403900, São Paulo, Brazil. fabipediatria@hotmail.com

Insights

The six-minute walk test (6MWT) Z-score shows a weak but significant correlation with cystic fibrosis (CF) severity markers like FEV1 and BMI in children. This study introduces Z-scores for 6MWT to account for age and gender biases in CF patient assessments.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Exercise Physiology
  • Biostatistics

Background:

  • The six-minute walk test (6MWT) is increasingly utilized in pediatric cystic fibrosis (CF) care.
  • Limited research correlates 6MWT with established CF severity indicators in children.
  • Previous studies lacked age and gender normalization of 6MWT data using Z-scores.

Purpose of the Study:

  • To investigate the correlation between the 6-minute walk test Z-score (Z-6MWT) and key CF severity parameters in pediatric patients.
  • To assess the utility of Z-scores in standardizing 6MWT for children with CF.
  • To evaluate the relationship between Z-6MWT and FEV1, BMI, chest radiography (CXR), and chest tomography (CT) findings.

Main Methods:

  • A cross-sectional descriptive study design was employed.
  • Spearman correlation analysis was used to examine relationships.
  • Data collected included FEV1, BMI Z-score, CXR, CT, and Z-6MWT from 34 clinically stable CF patients aged 6-21 years.

Main Results:

  • The mean Z-6MWT among the 34 participants (14F/20M, mean age 12.1±4.0 years) was -1.1±1.106.
  • Significant correlations were observed between Z-6MWT and FEV1 (r=0.59, p=0.0002), BMI Z-score (r=0.42, p=0.013), CXR (r=0.34, p=0.0472), and CT (r=-0.45, p=0.0073).
  • These correlations, while statistically significant, were generally poor in magnitude.

Conclusions:

  • A significant but weak correlation exists between the Z-6MWT and current markers of CF severity in pediatric patients.
  • The use of Z-scores for 6MWT may offer a more standardized approach for assessing functional capacity in children with CF.
  • Further research is warranted to explore the clinical utility of Z-6MWT in managing CF.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores help...